logo

For the Inventor, By the Inventor

Lexington, MA, United States of America

Shire Viropharma Incorporated


USPTO Granted Patents = 11



Trademarks = 3

Forward Citations = 30

Loading Chart...
Loading Chart...

12 inventors (with patents filed for the assignee):

goldMedal Stephen Ruddy (5 out of 7 patents)

silverMedal Mark Cornell Manning (5 out of 85 patents)

bronzeMedal Ryan Erik Holcomb (5 out of 15 patents)

4.  Colin Broom (3 out of 4 patents)

5.  Jeffrey Dayno (2 out of 3 patents)

6.  John D Peabody, Iii (2 out of 6 patents)

7.  Marc E Uknis (1 out of 7 patents)

8.  Jörgen Johnsson (1 out of 4 patents)

9.  Hans Lennernäs (1 out of 13 patents)

10.  Thomas Hedner (1 out of 11 patents)

11.  Gudmundur Johannsson (1 out of 4 patents)

12.  Stanko Skrtic (1 out of 6 patents)

13.  Elaine Phillips (10 patents)

14.  Malcolm Hill (13 patents)

15.  Adam Simpson (19 patents)


11 patents:

1. 10786557 - Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders (2020-09-29),
2. 10765692 - Maribavir isomers, compositions, methods of making and methods of using (2020-09-08),
3. 10583146 - Pharmaceutical compositions for glucocorticoid replacement therapy (2020-03-10),
4. 10485813 - Maribavir isomers, compositions, methods of making and methods of using (2019-11-26),
5. 10272142 - Compositions and methods useful for the treatment of neuromyelitis optica spectrum disorders (2019-04-30),
6. 10201595 - C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency (2019-02-12),
7. 10130690 - C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency (2018-11-20),
8. 10105423 - C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency (2018-10-23),
9. 10080788 - C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency (2018-09-25),
10. 9895428 - Methods of treating antibody-mediated rejection in organ transplant patients with C1-esterase inhibitor (2018-02-20),
11. 9616111 - C1-INH compositions and methods for the prevention and treatment of disorders associated with C1 esterase inhibitor deficiency (2017-04-11),
Company Overview
Shire Viropharma Incorporated, based in Lexington, MA, is a biopharmaceutical company focused on developing innovative therapies for rare diseases. The organization specializes in the research and manufacture of treatments that address unmet medical needs, particularly in the areas of infectious diseases and immunology. With a commitment to advancing healthcare solutions, Shire Viropharma leverages cutting-edge technology and scientific expertise to improve patient outcomes and enhance quality of life for those affected by complex conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

11 Patents

#62 in Lexington, MA

#1,661 in Massachusetts

#27,490 in US

#51,714 in the World

Lexington, MA (US)
Lexington, MA, United States of America

Shire Viropharma Incorporated

Forward Citations = 30

12 inventors:

goldMedal Stephen Ruddy (5 out of 7 patents)

silverMedal Mark Cornell Manning (5 out of 85 patents)

bronzeMedal Ryan Erik Holcomb (5 out of 15 patents)

4.  Colin Broom (3 out of 4 patents)

5.  Jeffrey Dayno (2 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Shire Viropharma Incorporated. Retrieved from https://idiyas.com/company/shire-viropharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…